US 11433143
Nano-enabled immunotherapy in cancer
granted A61KA61K47/542A61K47/544
Quick answer
US patent 11433143 (Nano-enabled immunotherapy in cancer) held by The Regents of the University of California expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K47/542, A61K47/544, A61K47/551, A61K47/554